GSK · NYSE
GSK (GSK) Stock Price & Fundamentals
$207.74−1.33%−$2.79End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
GSK (GSK) closed at $207.74 on Oct 9, 2026, down 1.33% from the previous close of $210.53.
Share price, past year
1Y +11.94%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $207.74 |
| Sep 30, 2026 | $211.53 |
| Aug 31, 2026 | $199.68 |
| Jul 31, 2026 | $197.60 |
| Jun 30, 2026 | $196.23 |
| May 29, 2026 | $184.84 |
| Apr 30, 2026 | $190.46 |
| Mar 31, 2026 | $190.35 |
| Feb 27, 2026 | $186.62 |
| Jan 30, 2026 | $199.95 |
| Dec 31, 2025 | $192.70 |
| Nov 28, 2025 | $188.87 |
| Oct 31, 2025 | $178.19 |
Key statistics
- 52-week range
- $176.54 – $215.31
Financials
GSK reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- GSK plc
- Ticker
- GSK
- Exchange
- NYSE
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 79 New Oxford Street, London, WC1A 1DG
- Incorporated in
- X0
- SEC CIK
- 0001131399
Frequently asked questions
What is GSK's stock price?
GSK (GSK) closed at $207.74 on Oct 9, 2026, down 1.33% from the previous close of $210.53.
Sources and methodology
Fundamentals come from GSK plc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures